Benzinga | Aug 9, 2021 04:57PM EDT

Recro Pharma Q2 EPS $0.03 Beats $(0.11) Estimate, Sales $18.02M Beat $17.10M Estimate

Recro Pharma (NASDAQ:REPH) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.11) by 127.27 percent. This is a 112 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $18.02 million which beat the analyst consensus estimate of $17.10 million by 5.36 percent. This is a 16.07 percent increase over sales of $15.52 million the same period last year.